Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like Voyager Therapeutic's Parkinson's Trial Shows Positive Results March 8, 2018 Sanofi Pasteur Inks $645 Million RSV Deal With AstraZeneca PLC's MedImmune March 2, 2017 Merck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche's Failed June 26, 2017
Merck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche's Failed June 26, 2017
